November 2023 – content
Life Sciences
PacBio acquires versatile super-resolution optics for short-read sequencing
Acquisition marries 3D cell culture with patch clamp technology
Research marketplace eyes Europe
Acquisition expands Qiagen’s forensics market ambitions
Randox acquires benchtop FC technology
EMS and Azer combine to build LS and Dx platform
Genomenon buys genomic curation company
Bio-Rad and Qiagen settle dPCR dispute
General Laboratory
Iron Path Capital forges chemicals platform with acquisition
Hamamatsu makes second NKT Photonics bid
Lab equipment maintenance firm makes two acquisitions
Lab furniture company buys stake in Lab Concept
Bejing Labtech open Tianjin facility
Two purchases expand optical capabilities of G&H
Zeiss invests in AR, camera tracking and semiconductor manufacturing
Process & hand-held instrumentation
Veolia sells UK industrial water analysis laboratory
Waters and Sartorius expand process analytical deal
Badger Meter lays foundation of process analytical business with two purchases
Sartorius enters two partnerships for Biostat bioreactors
Kromek expands wearable distribution deal with Smiths Detection
Financials
Qiagen tones down FY2023 forecast
PacBio expands product portfolio through acquisitions
Temporary consumables decline sparks Illumina forecast adjustment
Consumable sales almost double at BioNano Genomics
BD Biosciences sees growth in reagents and flow cytometry instruments
LS division grows slowest at Gooch & Housego
China declines in high teens during Waters’ second quarter
Stagnating sales at Waldner
Organic growth in the mid teens at Bruker, driven by Asian customers
Zeiss IQR grows in high single-digits in first fiscal half
Köttermann’s sales below expectations in 2021
Global slowdown results in Hamamatsu toning down full-year guidance
Acquired product lines exceed expectations at Netzsch A&T
Kewaunee back in profit after three difficult years
OSI Systems growth driven by cargo and vehicle inspection systems
Veolia Water Technologies driven by Suez’ WTS in first half 2023
Getinge LS sees decline in biopharma sales
Appointments
